Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01027013 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye

A Phase 2 study of Dry Eye Syndromes and Keratoconjunctivitis Sicca, sponsored by Kubota Vision.

Completed
Registry status
Phase 2
Development phase
220
Enrollment target
5
Study locations

NCT01027013 is a Phase 2 study of Dry Eye Syndromes and Keratoconjunctivitis Sicca that has completed, run by Kubota Vision. The registered enrollment target is 220 participants, below the 401-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (45% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01027013, a Phase 2 study of Dry Eye Syndromes and Keratoconjunctivitis Sicca, has completed, sponsored by Kubota Vision.

COMPLETED
Registry status
Phase 2
Development phase
220 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to evaluate the safety and efficacy of rebamipide 2% suspension for the treatment of patients with dry-eye.

Conditions Studied

Dry Eye Syndromes Keratoconjunctivitis Sicca

Interventions

  • DRUG rebamipide 2% ophthalmic suspension
  • DRUG placebo eye drops

Study Locations (5)

Connecticut

  • The Eye Care Group, P.C. - Waterbury

Kentucky

  • Richard Eiferman, MD - Louisville

Maine

  • Central Maine Eye Care - Lewiston

Massachusetts

  • Ora, Inc - Andover

Tennessee

  • Total Eye Care, P.A. - Memphis

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2009-12
Est. Completion 2010-11
Phase Phase 2

Sponsor

Kubota Vision

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01027013

The ClinicalTrials.gov registry entry for NCT01027013 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 401-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (45% lower). The listed sponsor is Kubota Vision, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dry Eye Syndromes appearing as the primary indexed condition, and to 2 interventions - of which rebamipide 2% ophthalmic suspension is the first listed.

NCT01027013 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Connecticut, Kentucky, Maine.

Frequently Asked Questions

What is clinical trial NCT01027013 about?

NCT01027013 is a clinical study titled "Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye". The purpose of this study is to evaluate the safety and efficacy of rebamipide 2% suspension for the treatment of patients with dry-eye.

What is the current status of trial NCT01027013?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 220 participants. The study started on 2009-12. Estimated completion is 2010-11.

What conditions does trial NCT01027013 study?

This clinical trial studies the following conditions: Dry Eye Syndromes, Keratoconjunctivitis Sicca.

What interventions are being tested in trial NCT01027013?

The interventions under investigation include: rebamipide 2% ophthalmic suspension (DRUG), placebo eye drops (DRUG).

Who is sponsoring clinical trial NCT01027013?

This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01027013 being conducted?

This trial has 5 study locations across Connecticut, Kentucky, Maine, Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dry Eye Syndromes

All registered trials for this condition

Keratoconjunctivitis Sicca

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.